Career Development Program

职业发展计划(CDP)是这一白血病孢子应用的重要组成部分 和国家孢子计划，因为它将确保一支从事翻译工作的学术教职干部 科学家致力于发现和应用新的方法来理解病因学和流行病学， 白血病患者的预防、诊断、治疗和治疗。我们CDP的目标是招募， 提供培训和指导(即指导和发展)并留住学术教员级别的物理学家， 临床医生-研究人员和实验室科学家，他们将致力于 白血病转化性研究。我们的重点将主要放在招聘助理教授上。我们会 特别重视招聘合格的妇女和少数群体。事实上，三位候选人都是 第一年被选中的职位是女性，一名是少数族裔。而任何地区的转化性白血病 我们将考虑研究，我们将特别重视我们的优势领域，包括人类 癌症遗传学、动物模型以及临床前和临床实验治疗学。 目标是为三个职位提供资金，每个职位10万美元，为期一到三年。应用程序将是 从俄亥俄州立大学综合癌症中心的所有部门和中心征集 (OSUCCC)和孢子管理核心。他们将接受资格和多样性的筛选 CDP领导人在正式审查开始之前，确保人才库中有合格的妇女和少数族裔。 申请将根据候选人的潜力、拟议研究的实力进行评判 以及导师的适当性。申请将按以下方式正式审查、评分和排名 孢子CDP指导委员会成员。最终遴选将由CDP领导人和 孢子项目主任与孢子执行委员会协商。每个职位都将是 资助一年，第二年和第三年的资格取决于令人满意的年度进展 经过获奖者的共同导师和孢子执行委员会的评估。孢子将会 每年为该计划提供150,000美元的资金；每年将提供150,000美元的配套资金 OSUCCC。该计划的成功将取决于该计划产生的科学的质量和质量 获奖者，他们在获得外部同行评审资金方面的成功，他们在学术上的成功 在学术界和白血病翻译研究中的进展和保留。

The Career Development Program (CDP) is an important component of this Leukemia SPORE application and the national SPORE program because it will assure a cadre of academic faculty who are translational scientists dedicated to discover and apply new approaches to understanding the etiology and epidemiology, prevention, diagnosis, treatment and cure of patients with leukemia. The goal of our CDP is to recruit, provide training and guidance {i.e. mentor and develop) and retain academic faculty level physicianscientists, clinician-investigators, and laboratory-based scientists who will dedicate their endeavors to leukemia translational research. Our focus will be primarily on recruitment of assistant professors. We will place special emphasis on recruiting qualified women and minorities. Indeed, all three of the candidates chosen for the first year positions are women and one is a minority. While any area of translational leukemia research will be considered, we will place special emphasis in our areas of strength which include human cancer genetics, animal models and preclinical and clinical experimental therapeutics. The goal will be to fund three positions at $100,000 each for one to three years. Applications will be solicited from all departments and centers at the Ohio State University Comprehensive Cancer Center (OSUCCC) and by the SPORE Administrative Core. They will be screened for eligibility and diversity by the CDP Leader before formal review begins to assure that the pool contains qualified women and minorities. Applications will be judged based on the potential of the candidate, the strength of the proposed research and the appropriateness of the mentors. Applications will be formally reviewed, scored and ranked by members of the SPORE CDP Steering Committee. Final selection will be made by the CDP Leader and SPORE Program Director in consultation with the SPORE Executive Committee. Each position will be funded for one year, with eligibility for a second and third year dependent upon satisfactory annual progress following evaluation by the awardee's co-mentors and the SPORE Executive Committee. The SPORE will provide $150,000 annual funding to the program; $150,000 annually in matching funds will be provided from the OSUCCC. Success of the program will be judged by the quality, of the science generated by the awardees, their success in obtaining external peer reviewed funding, their success in academic advancement and their retention in academia and leukemia translational research.